The immune haemolytic anaemias: A century of exciting progress in understanding

British Journal of Haematology

Volumn 114, Issue 4, 2001, Pages 770-785

  Dacie, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Auto antibodies; Auto immune haemolytic anaemia (AIHA); Drug induced AIHA; Immune haemolytic anaemia

Indexed keywords

AUTOANTIBODY; COLD AGGLUTININ; DANAZOL; ERYTHROCYTE ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLDOPA; VINCA ALKALOID;

ANTIBODY SPECIFICITY; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ERYTHROPHAGOCYTOSIS; HEMAGGLUTINATION; HEMOLYTIC ANEMIA; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SEROLOGY; SPHEROCYTOSIS; TERATOMA; THROMBOCYTOPENIA;

ADRENOCORTICOTROPIC HORMONE; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODY SPECIFICITY; ANTIHYPERTENSIVE AGENTS; AUTOANTIBODIES; BLOOD TRANSFUSION; COLITIS, ULCERATIVE; CORTISONE; ERYTHROCYTES; HEPARIN; HISTORY, 20TH CENTURY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPROLIFERATIVE DISORDERS; METHYLDOPA; SPLENECTOMY;

EID: 0034800395     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02945.x     Document Type: Review

References (223)

1. The collagen diseases
2. Efficacy of danazol in hematologic disorders
3. The treatment of idiopathic thrombocytopaenia with vinblastine-loaded platelets
4. Treatment of autoimmune hemolytic anemia with Vinca-loaded platelets
5. Danazol therapy for autoimmune hemolytic anemia
6. Idiopathic acquired autoimmune hemolytic anemia; a review of forty-seven cases treated from 1955 through 1965
7. Ueber die kälteagglutination der rotten blutkörperchen
8. Intorno agli itteri emolitici. Effetti della splenectomia su di una particulare forma di ittero emolitico acquisato con anemia a tipo pernicioso
9. The determination of the length of life of transfused blood corpuscles in man
10. Some data on the range of life of transfused blood corpuscles in persons without idiopathic blood disease
11. Maladie pa autoaggression. Akute hämolytische anamie, thrombocytopeniche purpura und graunlocytopen
12. Specific immunoadsorption of IgG antibody in a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia. A new form of therapy for the acute critical stage
13. Étude des différentes étapes de l'érythro-phagocytose par microcinematographie et microscopie électronique à balayage
14. Spontaneous haemolytic anaemia in mice of the NZB/BL strain
15. 'Actively acquired tolerance' of foreign cells
16. Autohaemagglutinins. With special reference to cold autoagglutinins with ABO-blood group specificity
17. The combined study of agglutination, hemolysis and erythrophagocytosis. With special reference to acquired hemolytic anemia
18. Haemolytic icterus (acholuric jaundice) congenital and acquired
19. Plasma exchange in the treatment of immune disease
20. The destruction of transfused erythrocytes in anaemia
21. A modification of Jerne's theory of antibody production using the concept of clonal selection
22. An experimental model of autoimmune haemolytic anaemia
23. A reassessment of the forbidden clone hypothesis of autoimmune disease
24. Auto-immune disease. I. Modern immunological concepts
25. Utilisation des gammaglobulines intraveineuses à fortes doses dans le traitment des anémies hémolytique auto-immunes
26. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin
27. Sur les variations quantitatives et qualitatives des globules rouges provoquées chez le lapin par les injections de serum hémolytique
28. Methyldopa and haemolytic anaemia
29. Incidence of a positive direct Coombs test in patients on α-methyldopa
30. Observations on the mechanism of hemolytic transfusion reactions occurring without demonstrable hemolysin
31. Ictère hémolytique acquis traité notament par deux exsanguinotransfusions
32. Hémoglobinique hémolysinique avec ictère polycholique aigu
33. Anémie grave avec hémolysine dans la serum; ictère hémolysinique
34. Agammaglobulinaemia with splenomegaly
35. A study of an autoagglutinin occurring in a human serum
36. Immunologic precursors of autoimmune hematologic disorders. Autoimmune hemolytic anemia and thrombocytopenia purpura
37. On certain properties of antisera prepared against human serum and its various protein fractions: Their use in the detection of sensitization of human red cells with 'incomplete' Rh antibody, and on the nature of this antibody
38. A new test for the detection of weak and 'incomplete' Rh agglutinins
39. Azathioprine therapy of 'autoimmune' disease
40. Autoimmunity in patients treated with levodopa
41. Splenic destruction of Rh-sensitized and of heated red cells
42. Differences in the agglutinability of human red cells by the high-titre cold antibodies of acquired haemolytic anaemia
43. The pathogenesis of spherocytes and leptocytes (target cells)
44. Autoimmune hemolytic anemia. I. Analysis of hematologic observations with particular reference to their prognostic value. A survey of 57 cases
45. Relation between characteristics of blood-group antibodies in vitro and associated pattern of red-cell destruction in vivo
46. Differences in behaviour of sensitized red cells to agglutination by antiglobulin sera
47. Serology of acquired haemolytic anemia
48. Modern concepts on autoimmune haemolytic anaemia
49. Specificity of auto-antibodies in acquired haemolytic anaemia
50. Auto-immune haemolytic anaemias
51. 'Incomplete' cold antibodies: Role of complement in sensitization to antiglobulin serum by potentially haemolytic antibodies
52. In discussion on ACTH in leukemia
53. Acquired hemolytic anemia: Physiopathology with particular reference to autoimmunization and therapy
54. The treatment of acquired hemolytic anemia. With a note on the relationship of periarteritis nodosa to hemolytic anemia
55. Hemolysins as the cause of clinical and experimental hemolytic anemias. With particular reference to the mature of spherocytosis and increase fragility
56. The presence of hemolysins in acute hemolytic anemia; preliminary note
57. Acute hemolytic anaemia (acquired hemolytic icterus, acute type)
58. Treatment of certain autoimmune diseases with antimetabolites; a preliminary report
59. The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH)
60. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia
61. Clinical trials of ACTH in haemolytic anaemia
62. The Hume lectures on haemolytic icterus
63. The diagnosis and management of acquired haemolytic anaemia
64. Anémie hémolytique acquise et réaction de Coombs
65. Dissociation of human serum macroglobulins
66. Ueber paroxysmale hämoglobinurie
67. Rôle probable d'un facteur héréditaire dans le determinisme de certaines anémies hémolytiques par auto-anticorps
68. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: Analysis of 637 cases and comparison with myeloproliferative diseases
69. The pathology of paroxysmal haemoglobinuria
70. Ueber hämolysine. Dritte mittheilung
71. The effect of splenic nerve resection and sympathetic ganglionectomy in a case of paroxysmal hemoglobinuria
72. Acute hemolytic anemia with autoagglutination; a case report
73. Acquired hemolytic anemia. I. The relation of antibody activity to activity of the disease. II. The significance of thrombocytopenia and leukopenia
74. The serology of autoimmune hemolytic disease. Observations on forty-one patients
75. Demonstration of antibodies in acquired hemolytic anemia with anti-human globulin serum
76. Primary thrombocytopenic purpura and acquired haemolytic anemia. Evidence for a common etiology
77. The blood group Ii system: A carbohydrate antigen system defined by naturally occurring monoclonal or oligoclonal auto-antibodies in man
78. The cryptogenic acquired haemolytic anaemias
79. Physical properties of red cell agglutinins in acquired hemolytic anemia
80. In discussion on 'ACTH in leukemia'
81. The effect of adrenocorticotrophic hormone (ACTH) in idiopathic acquired hemolytic anemia as related to the hemolytic mechanisms
82. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests
83. Review: Immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs
84. T detected in a Caucasian American
85. T
86. Radiochromium in the selection of patients with haemolytic anaemia for splenectomy
87. The preparation and properties of cold hemagglutinin
88. Drug induced red blood cell auto-antibodies co-developed with drug-specific antibodies causing haemolytic anaemias
89. Drug-induced immune haemolyitc anaemias
90. Autoagglutination phänomene beim hämolytischen ikterus
91. Relation of increased hypotonic fragility and of erythrostasis to the mechanism of hemolysis in certain anemias
92. Erythrophagocytic anemia (Lederer's anemia?). Report of a case with recovery
93. Studies on the mechanism of drug-induced hemolytic anemia
94. Studies on the mechanism of a drug-induced hemolytic anemia
95. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases
96. Serologic and physiocochemical characterization of Donath-Landsteiner antibodies from six patients
97. Chlorambucil treatment of patients with cold agglutinin syndrome
98. Specificity of antibodies in acquired haemolytic anaemia
99. Study of the erythrocyte survival time in a case of acquired haemolytic anaemia
100. Zur klinik der splenomegalen lymphogranulomatose
101. Implications cliniques de la nouvelle classification immunologiques des anémies hémolytiques avec auto-anticorps
102. Cold agglutinins: A diagnostic aid in certain types of primary atypical pneumonia
103. Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes
104. Human monocytes; distinct receptor sites for the third component of complement and for immunoglobulin G
105. Chronic lymphatic leukaemia with haemolytic anaemia. Splenectomy
106. Plasma exchange: A selective form of blood-letting
107. Haemolytic (spherocytic) jaundice in the adult
108. I blood group system and its relation to other blood group systems
109. Some messages received from blood group antibodies
110. b and other auto-antibodies responsible for positive direct antiglobulin tests in 150 individuals
111. Absence of autoanti-Jk3 as a component of anti-dl
112. Current concepts in therapy. Hemolytic anemia
113. Agglutination of sensitized red cells by large anisometric molecules
114. The destruction of red cells by antibodies in man. 1. Observations on the sequestration and lysis of red cells altered by immune mechanisms
115. Infectious mononucleosis: An unsuspected source of anti-i
116. The I antigen and antibody
117. Treatment of idiopathic autoimmune hemolytic anemia in children
118. Thymectomy in an infant with autoimmune haemolytic anaemia
119. Hemolytic anemia associated with atypical hemagglutinins
120. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes
121. Untersuchungen über zusamanhänge zwischen erworbenen hämolytischen anämien, klassischen blutgruppen, rhesusfactor, geschlecht und alter
122. Ueber beziehungen zwischen dem blutserum und den körperzellen
123. A form of acute hemolytic anemia probably of infectious origin
124. Three additional cases of acute hemolytic (infectious) anemia
125. Ictère hémolytique congenital et ictère hémolytique acquis
126. The specificity of the antibody in paroxysmal cold hemoglobinuria
127. Penicillamine treatment in the cold-haemagglutinin syndrome
128. Red cells coated with immunoglobulin G: Binding and sphering by mononuclear cells in man
129. Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome
130. Association of antibody-coated red blood cells with ulcerative colitis
131. Anti-i: A cold antibody defining the Ii relationship of human red cells
132. Anti-i: A new cold antibody
133. Immunological tolerance
134. The hematologic aspects of disseminated (systemic) lupus erythematosus
135. Unmittelbare effekte der splenektomie bei einem fall von erworbenen hämolytischen splenomegalischen ikterus, Typus hayem-widal
136. La panemoagglutinina del sangue umane
137. The survival of transfused erythrocytes, with special reference to cases of acquired haemolytic anaemia
138. Measurement of survival and destruction of red cells in haemolytic syndromes
139. Direct antiglobulin (Coombs) reactions in patients with connective tissue diseases
140. The anaemia produced by a haemolytic serum
141. Immunpancytopenien
142. Drug therapy of autoimmune hemolytic anemia
143. Hämolytische anämie, leukopenie und purpura bei lymphogranulomatose
144. Chlorambucil treatment of the cold agglutinin syndrome
145. Acquired haemolytic jaundice
146. Über atypische hämolytische anämien
147. Cold agglutinins (autohemagglutinins) in primary atypical pneumonias
148. Acquired haemolytic anaemia
149. Autoimmune haemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships
150. Hereditary aspects of autoimmune hemolytic anemia, a retrospective analysis
151. Autoimmune haemolytic anemia II. Therapeutic aspects
152. Syndrome of hypogammaglobulinaemia, splenomegaly and hypersplenism
153. Autohemolysinic anemia with auto-agglutination: Improvement after splenectomy
154. The role of autoagglutinins in hemolytic anemias
155. Effect of mercaptanes in cold agglutinin disease
156. A review. Cold agglutination. Antibodies and antigens
157. Cold agglutination
158. Transfusion therapy for autoimmune hemolytic anemia
159. Complement and the antiglobulin test
160. The auto-immune hemolytic anemia of malignant lymphocytic disease
161. Paroxysmal hemaglobinuria with vasomotor and agglutinative features
162. Destruction the red blood corpuscles in health and disease
163. IgG therapy in autoimmune haemolytic anaemia of warm type
164. Thermostabliles, nicht komplexes (Auto-) hämolysin dei transitorischer kältehämoglobinurie
165. The treatment of autoimmune hemolytic anemia with 6-mercaptopurine and thioguanine
166. Autoimmune hemolytic anemia: Clinical correlations and biological implications
167. Autoimmune haemolytic anaemia and mefenamic acid therapy
168. Symptomatic hemolytic anemia
169. Immunosuppressive therapy (First two parts)
170. Hemolytic anemia secondary to mesantoin
171. Autoimmune haemolysis: An 18-year study of 865 cases referred to a regional transfusion centre
172. Cold hemagglutination - An interpretive review
173. Electrophoresis and antibody nitrogen determinations of a cold hemagglutinin
174. A new antibody in serum of patients with acquired hemolytic anemia
175. Prednisone (Meticorten) in treatment of acquired hemolytic anemia
176. Surface counting in the assessment of sites of red cell destruction (Annotation)
177. Further studies of the I antigen and antibody
178. Anémie auto-hémolytique chez un nouveau-né
179. Varieties of specific auto-antibodies in acquired haemolytic anaemia
180. Varieties of specific auto-antibodies in acquired haemolytic anaemia (II)
181. Observations on a prozone phenomenon encountered in using the anti-globulin sensitization test
182. Two different serologic mechanisms of paroxysmal cold hemoglobinuria, illustrated by three cases
183. Serologic studies in acquired hemolytic anemia
184. Auto-immune haemolytic anaemia in some malignant systemic diseases
185. Auto-immune haemolytic anaemia in systemic lupus erythematosus
186. Anti-HI, a new cold antibody of the H.O.I. complex. A preliminary report
187. Monoclonal antibodies - C3 serology
188. Studies on the destruction of red blood cells. VI. The spleen as a source of a substance causing agglutination of the red blood cells of certain patients with acquired hemolytic jaundice by an antihuman serum rabbit serum (Coombs' serum)
189. On the influence of immune hemolysin on red blood corpuscles in vivo and in vitro
190. Symptomatic and hemopathic hemolytic anemia
191. Acquired haemolytic jaundice in a woman previously splenectomized for essential thrombocytopenia
192. Serology of acquired hemolytic anemias
193. Serological findings in a case of haemolytic anaemia, with some general observations on the pathogenesis of this syndrome
194. Splenectomy and blood dyscrasias
195. Failed splenectomy in acholuric jaundice and the relation of toxaemia to the haemolytic crisis
196. An unusual case of autoagglutination
197. Auto-agglutinations des hématies dans l'ictère hémolytique acquis
198. Les ictères d'origine hémolytique
199. Conglutination test for Rh sensitization
200. Studies on auto-antibodies in human sera
201. Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions. Biologic test with bovine red cells
202. Autoimmune haemolytic anaemia in an infant treated by thymectomy
203. Immune drug-induced haemolytic anaemia
204. Immune drug-induced hemolytic anemias
205. Autoimmune haemolytic anaemia associated with α-methyldopa therapy
206. Immunosuppressive drugs in the treatment of autoimmune haemolytic anaemias
207. In vitro erythrophagocytosis in acquired hemolytic anemia
208. The results of prolonged treatment of autoimmune haemolytic anaemia
209. Lupus erythematosus - An auto-antibody disease